120.45
Schlusskurs vom Vortag:
$122.33
Offen:
$120.95
24-Stunden-Volumen:
1.53M
Relative Volume:
0.86
Marktkapitalisierung:
$28.87B
Einnahmen:
$8.60B
Nettoeinkommen (Verlust:
$906.00M
KGV:
32.47
EPS:
3.71
Netto-Cashflow:
$889.00M
1W Leistung:
+1.54%
1M Leistung:
+15.15%
6M Leistung:
-2.65%
1J Leistung:
-13.47%
Xylem Inc Stock (XYL) Company Profile
Firmenname
Xylem Inc
Sektor
Telefon
202-869-9150
Adresse
301 WATER STREET SE, WASHINGTON, NY
Vergleichen Sie XYL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
XYL
Xylem Inc
|
120.45 | 28.87B | 8.60B | 906.00M | 889.00M | 3.71 |
![]()
ETN
Eaton Corporation Plc
|
298.11 | 112.45B | 25.31B | 3.94B | 3.32B | 9.91 |
![]()
GEV
Ge Vernova Inc
|
401.23 | 101.31B | 35.71B | 1.94B | 3.34B | 6.94 |
![]()
PH
Parker Hannifin Corp
|
613.92 | 79.02B | 19.79B | 3.39B | 3.13B | 25.97 |
![]()
ITW
Illinois Tool Works Inc
|
239.87 | 70.92B | 15.76B | 3.37B | 2.85B | 11.37 |
![]()
EMR
Emerson Electric Co
|
107.27 | 59.26B | 17.55B | 2.41B | 3.27B | 4.19 |
Xylem Inc Stock (XYL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2024-12-09 | Hochstufung | Citigroup | Neutral → Buy |
2024-09-03 | Herabstufung | TD Cowen | Buy → Hold |
2024-08-13 | Eingeleitet | UBS | Buy |
2024-03-12 | Eingeleitet | Exane BNP Paribas | Outperform |
2024-01-04 | Hochstufung | Raymond James | Underperform → Mkt Perform |
2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
2023-11-21 | Hochstufung | Deutsche Bank | Hold → Buy |
2023-10-19 | Hochstufung | Oppenheimer | Perform → Outperform |
2023-10-02 | Hochstufung | Melius | Neutral → Overweight |
2023-08-29 | Eingeleitet | Seaport Research Partners | Neutral |
2023-06-29 | Eingeleitet | Deutsche Bank | Hold |
2023-06-08 | Fortgesetzt | Goldman | Buy |
2023-05-31 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2023-01-24 | Hochstufung | Stifel | Hold → Buy |
2023-01-04 | Herabstufung | Raymond James | Mkt Perform → Underperform |
2022-12-19 | Herabstufung | Stifel | Buy → Hold |
2022-11-16 | Hochstufung | Atlantic Equities | Neutral → Overweight |
2022-10-18 | Hochstufung | Cowen | Market Perform → Outperform |
2022-08-03 | Hochstufung | Credit Suisse | Underperform → Neutral |
2022-07-20 | Hochstufung | Stifel | Hold → Buy |
2022-07-15 | Eingeleitet | Northcoast | Neutral |
2022-06-01 | Hochstufung | Cowen | Market Perform → Outperform |
2022-04-05 | Hochstufung | Raymond James | Underperform → Mkt Perform |
2022-01-04 | Herabstufung | Raymond James | Mkt Perform → Underperform |
2021-12-17 | Eingeleitet | Mizuho | Neutral |
2021-11-23 | Eingeleitet | Loop Capital | Hold |
2021-10-01 | Herabstufung | Rosenblatt | Buy → Neutral |
2021-06-18 | Eingeleitet | Argus | Buy |
2021-05-05 | Hochstufung | Goldman | Sell → Neutral |
2021-03-31 | Eingeleitet | Morgan Stanley | Overweight |
2021-01-08 | Herabstufung | Cowen | Market Perform → Underperform |
2021-01-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2020-12-15 | Herabstufung | Stifel | Buy → Hold |
2020-07-14 | Hochstufung | Rosenblatt | Neutral → Buy |
2020-05-15 | Hochstufung | Vertical Research | Sell → Hold |
2020-04-16 | Herabstufung | Vertical Research | Hold → Sell |
2020-04-08 | Herabstufung | Goldman | Neutral → Sell |
2020-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2020-03-27 | Herabstufung | Oppenheimer | Outperform → Perform |
2020-03-26 | Hochstufung | Berenberg | Sell → Hold |
2020-03-23 | Herabstufung | Boenning & Scattergood | Outperform → Neutral |
2020-03-10 | Herabstufung | Credit Suisse | Neutral → Underperform |
2020-02-14 | Eingeleitet | Rosenblatt | Neutral |
2019-12-17 | Eingeleitet | Citigroup | Neutral |
2019-12-05 | Herabstufung | Jefferies | Buy → Hold |
2019-11-04 | Herabstufung | Seaport Global Securities | Buy → Neutral |
2019-09-20 | Eingeleitet | Jefferies | Buy |
2019-08-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
2019-05-14 | Herabstufung | Cowen | Outperform → Market Perform |
2019-05-03 | Hochstufung | Janney | Neutral → Buy |
2019-03-29 | Herabstufung | Janney | Buy → Neutral |
2018-12-19 | Hochstufung | Stifel | Hold → Buy |
Alle ansehen
Xylem Inc Aktie (XYL) Neueste Nachrichten
Fast 15: Joseph Leidy - Talk Business & Politics
Xylem's (NYSE:XYL) five-year earnings growth trails the solid shareholder returns - Yahoo Finance
Xylem's (NYSE:XYL) 15% CAGR outpaced the company's earnings growth over the same five-year period - simplywall.st
Xylem First Quarter 2025 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Hot Springs Combats Aging Infrastructure Challenges With Xylem Digital Solutions - Water Online
Xylem Holds its own with 1.8-Percent First Quarter 2025 Revenue Increase - Rental Equipment Register
BNP Paribas Exane Adjusts Xylem's Price Target to $142 From $129 - marketscreener.com
Oppenheimer Adjusts Xylem's Price Target to $147 From $145 - marketscreener.com
Goldman Sachs Adjusts Xylem's Price Target to $153 From $160 - marketscreener.com
Xylem (XYL) Price Target Raised by RBC Capital Amid Solid Perfor - GuruFocus
Xylem (XYL) Price Target Raised by RBC Capital Amid Solid Performance | XYL Stock News - GuruFocus
Xylem price target raised to $141 from $140 at Stifel - TipRanks
Xylem (XYL) Target Price Increased by Stifel Analyst | XYL Stock News - GuruFocus
Xylem (XYL) Price Target Reduced by Baird Despite Positive Outlo - GuruFocus
Xylem (XYL) Price Target Reduced by Baird Despite Positive Outlook | XYL Stock News - GuruFocus
Xylem Inc. (NYSE:XYL) Q1 2025 Earnings Call Transcript - MSN
RBC Raises Price Target on Xylem to $147 From $143, Keeps Outperform Rating - marketscreener.com
Xylem Inc (XYL) Q1 2025 Earnings Call Highlights: Strong Start w - GuruFocus
Xylem Inc (XYL) Q1 2025 Earnings Call Highlights: Strong Start with Revenue and EPS Surpassing ... - Yahoo Finance
Xylem: Q1 Earnings Snapshot - CT Insider
Xylem beats Q1 earnings expectations, reaffirms 2025 outlook - MSN
Xylem Inc. Reports Strong Q1 2025 Results - TipRanks
Xylem reaffirms 2025 guidance with revenue target of $8.7B-$8.8B - MSN
Xylem Inc’s Earnings Call Highlights Strong Q1 Amid Challenges - TipRanks
Earnings call transcript: Xylem Q1 2025 earnings beat expectations - Investing.com Australia
Lobbying Update: $230,000 of XYLEM INC. lobbying was just disclosed - Nasdaq
Candler family regains hope with new well after losing water during Helene - WLOS
We Think Xylem's Smart Water Solutions Will Help Drive Profitable Growth - Morningstar
Press Release Distribution & PR Platform - ACCESS Newswire
Xylem (XYL) Surpasses Q1 Revenue Forecast with Strong Start to 2 - GuruFocus
Baird Adjusts Price Target on Xylem to $146 From $149, Keeps Outperform Rating - marketscreener.com
Xylem Boosts 2025 Revenue Forecast Thanks To Strong Demand - Finimize
Xylem Inc. (XYL) Exceeds Q1 Expectations and Reaffirms 2025 Guid - GuruFocus
Xylem Inc. 2025 Q1ResultsEarnings Call Presentation (NYSE:XYL) - Seeking Alpha
Xylem Inc. SEC 10-Q Report - TradingView
Xylem (XYL) Increases FY25 Revenue Outlook, Adjusted EBITDA Marg - GuruFocus
Xylem Surpasses Q1 2025 Revenue Expectations with $2.07 Billion in SalesNews and Statistics - IndexBox
Xylem's Q1 Earnings & Revenues Top Estimates, Orders Down Y/Y - Yahoo Finance
Xylem (XYL) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Xylem Reports First Quarter 2025 Results | XYL Stock News - GuruFocus
Xylem raises 2025 revenue forecast on strong water treatment equipment demand - marketscreener.com
Xylem announces First Quarter 2025 financial results, reporting revenues of $2.1 billion - Smart Water Magazine
Xylem Inc (XYL) Q1 Earnings: EPS Meets Estimates at $0.69, Reven - GuruFocus
Xylem (XYL) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Xylem beats Q1 earnings expectations, reaffirms 2025 outlook (XYL:NYSE) - Seeking Alpha
Xylem beats Q1 estimates, reaffirms 2025 outlook; shares rise - Investing.com Australia
Xylem beats Q1 estimates, reaffirms 2025 outlook; shares rise By Investing.com - Investing.com UK
Xylem Q1 Adjusted Earnings, Revenue Rise; 2025 Outlook Set - marketscreener.com
Xylem’s (NYSE:XYL) Q1 Sales Beat Estimates - Yahoo Finance
Finanzdaten der Xylem Inc-Aktie (XYL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):